The Oxford-based company, founded in 2011 and acquired by Stryker in May 2023, specializes in developing proprietary interventional neuroradiology devices. Their devices are used for the minimally invasive treatment of neurovascular diseases, including hemorrhagic strokes and various types of aneurysms. Cerus Endovascular's products, such as the e-clipse aneurysm occlusive device, offer alternatives to traditional surgical procedures like clipping, metal coils, and liquid embolics. These devices enable interventional neuroradiologists to treat intracranial aneurysms with less invasive techniques.